Cadence Capital Management’s Labcorp LH Stock Holding History

Cadence Capital Management’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-4,521	Closed	-$675K	–	545
2018 Q3	$675K	Buy	+4,521	New	+$688K	0.04%	456
2015 Q4	–	Sell	-16,668	Closed	-$1.55M	–	632
2015 Q3	$1.55M	Buy	16,668 +151	+0.9%	+$15.6K	0.11%	213
2015 Q2	$1.72M	Hold	16,517	–	–	0.1%	261
2015 Q1	$1.79M	Buy	+16,517	New	+$1.7M	0.11%	250

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cadence Capital Management's LH Position: Q4 2018 in Review

Cadence Capital Management sold out of Labcorp (LH) in Q4 2018, closing a stake of 4,521 shares — an estimated $675K sold.

Cadence Capital Management first reported a position in LH in Q1 2015 and held it in 4 quarters. The position peaked at $1.79M in Q1 2015. 742 funds tracked by Wall St. Rank hold LH as of Q4 2018.

Cadence Capital Management reported no remaining Labcorp position as of Q4 2018 after selling out during the quarter.
Cadence Capital Management sold 4,521 Labcorp shares in Q4 2018, an estimated $675K.
Cadence Capital Management first reported a position in Labcorp in Q1 2015 and held it in 4 quarters.
Cadence Capital Management's Labcorp position peaked at $1.79M in Q1 2015.
742 funds tracked by Wall St. Rank held Labcorp as of Q4 2018.

Based on Cadence Capital Management's 13F filing for Q4 2018, filed 13 Feb 2019.